| LOU/M |
post-insult time to onset of experimental autoimmune encephalomyelitis |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
5 |
11.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110796 |
3186 |
| LOU/M |
experimental autoimmune encephalomyelitis duration |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
5 |
8.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110800 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
5 |
100.0 |
% |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110792 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
rat anti-Hu-S102-129 T cell line (9 x 10E6 cells) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
3 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
110781 |
3186 |
| LOU/M |
post-insult time to onset of experimental autoimmune encephalomyelitis |
rat anti-Hu-MBP T cell line (9 x 10E6 cells) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
9 |
6.0 |
d |
1.0 |
3.0 |
in vivo visual assessment |
0.0 |
0 |
110783 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S102-129 (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
3 |
100.0 |
% |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110794 |
3186 |
| LOU/M |
post-insult time to onset of experimental autoimmune encephalomyelitis |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S102-129 (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
3 |
11.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110798 |
3186 |
| LOU/M |
post-insult time to onset of experimental autoimmune encephalomyelitis |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) and cyclophosphamide (8 mg) then cyclophosphamide (5 mg) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
11.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110797 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
0.0 |
% |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110790 |
3186 |
| LOU/M |
experimental autoimmune encephalomyelitis duration |
rat anti-Hu-MBP T cell line (9 x 10E6 cells) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
9 |
6.0 |
d |
1.0 |
3.0 |
in vivo visual assessment |
0.0 |
0 |
110784 |
3186 |
| LOU/M |
experimental autoimmune encephalomyelitis duration |
rat anti-Hu-S102-129 T cell line (9 x 10E6 cells) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
3 |
8.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
0.0 |
0 |
110789 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S110-129 (0.05-0.1 ml) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
0.0 |
% |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110791 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) and cyclophosphamide (5 mg) then cyclophosphamide (8 mg) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
100.0 |
% |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110793 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
rat anti-Hu-MBP T cell line (9 x 10E6 cells) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
9 |
100.0 |
% |
|
|
in vivo visual assessment |
0.0 |
0 |
110780 |
3186 |
| LOU/M |
post-insult time to onset of experimental autoimmune encephalomyelitis |
rat anti-Hu-S102-129 T cell line (9 x 10E6 cells) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
3 |
5.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
0.0 |
0 |
110782 |
3186 |
| LOU/M |
post-insult time to onset of experimental autoimmune encephalomyelitis |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S110-129 (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
11.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110799 |
3186 |
| LOU/M |
experimental autoimmune encephalomyelitis duration |
Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) and cyclophosphamide (8 mg) then cyclophosphamide (5 mg) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
11.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110801 |
3186 |
| LOU/M |
experimental autoimmune encephalomyelitis duration |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S110-129 (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
8.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110803 |
3186 |
| LOU/M |
experimental autoimmune encephalomyelitis duration |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S102-129 (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
3 |
8.0 |
d |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110802 |
3186 |
| LOU/M |
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time |
Freund's complete adjuvant (0.05-0.1 ml) and Hu-S110-129 (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) |
Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. |
central nervous system integrity trait |
not specified |
95 days-114 days |
4 |
100.0 |
% |
0.0 |
0.0 |
in vivo visual assessment |
2592000.0 |
0 |
110795 |
3186 |
